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Summary
Background.— Thrombus aspiration is applicable in a large majority of patients with acute
myocardial infarction (AMI) and results in better reperfusion and clinical outcomes compared
with percutaneous coronary intervention alone. Some aspiration procedures are, however, inef-Myocardial infarction fective. To date, few clinical data are available on the predictors of successful thrombectomy
in the acute phase of myocardial infarction.
Aims.— To determine the baseline clinical and angiographic characteristics associated with
successful thrombectomy.
Methods.— Consecutive patients with ST elevation myocardial infarction with a baseline TIMI
ﬂow of 0 or 1, who underwent thrombus aspiration and primary or rescue angioplasty, were
Abbreviations: AMI, acute myocardial infarction; NT-pro-BNP, n-terminal pro-b-type natriuretic peptide; PCI, percutaneous coronary
ntervention; RICO, observatoire des infarctus de Côte-d’Or; TIMI, thrombolysis in myocardial infarction.
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included. The main criterion for evaluation was an effective or ineffective aspiration deﬁned,
respectively, by the presence or absence of atherothrombotic material in the aspirate samples.
Results.— Among the 180 patients included, material was collected in 155 patients (86%).
Patients with the presence of material were younger (61 vs 74 years, P = 0.015), less frequently
hypertensive (41% vs 68%, P = 0.023) and had a lower systolic blood pressure at admission (135
vs 148mmHg, P = 0.031). No difference was observed between the two groups for angiographic
parameters except for visible thrombus (61% vs 28%, P = 0.005) and calciﬁcation (37% vs 60%,
P = 0.048). In multivariable analysis, the ability to remove the clot was affected by: age greater
than 70 years (odds ratio 0.18, 95% conﬁdence interval 0.06—0.51; P = 0.001), admission sys-
tolic blood pressure (0.97, 0.95—0.99; P = 0.003) and thrombus seen on angiography (4.54,
1.54—13.45, P = 0.006).
Conclusion.— The present study showed that manual thrombus aspiration is effective in most,
but not all, patients. Further studies are needed to develop more efﬁcient aspiration techniques
and other aspiration devices to improve the results of such procedures.
© 2010 Elsevier Masson SAS. All rights reserved.
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Résumé
Introduction.— La thrombectomie est le plus souvent possible lors des procédures intervention-
nelles chez les patients atteints d’infarctus aigu du myocarde avec sus-décalage du segment-ST
(IDM ST+), avec pour résultat une amélioration des critères de reperfusion et des événements
cliniques quand on la compare aux procédures d’angioplastie n’utilisant pas cette technique.
Cependant, certaines procédures d’aspiration sont inefﬁcaces. À ce jour, peu de données
cliniques sont disponibles sur les facteurs prédictifs de succès de la thrombectomie à la phase
aiguë de l’infarctus du myocarde.
Objectifs.— Déterminer les caractéristiques cliniques et angiographiques associées à un succès
de la thrombectomie.
Méthodes.— Tous les patients consécutifs avec un diagnostic d’IDM ST+ pris en charge pour
angioplastie primaire ou de sauvetage, et qui ont subi une thrombectomie ont été inclus. Le
critère primaire d’évaluation a été le succès ou l’échec de la procédure déﬁni respectivement
par la présence ou l’absence de matériel athérothrombotique dans les échantillons aspirés.
Résultats.— Parmi les 180 patients consécutifs inclus, la thrombectomie a permis le retrait
de matériel chez 155malades (86 %) (groupe T+). Ces patients étaient plus jeunes (61 vs
74 ans, p = 0,015), moins souvent hypertendus (41 % versus 68 %, p = 0,023) et avaient une pres-
sion artérielle systolique inférieure à l’admission (135 contre 148mmHg, p = 0,031). Aucune
différence n’a été observée entre les deux groupes pour les paramètres angiographiques
à l’exception des thrombus visibles et des calciﬁcations (respectivement, 61 % contre 28%,
p = 0,005 et 37 % contre 60%, p = 0,048). L’analyse statistique multivariée met en évidence que
l’âge supérieur à 70 ans [OR (IC 95%): 0,18 (0,06 à 0,51); p = 0,001], la pression artérielle sys-
tolique à l’admission (0,97; 0,95 à 0,99, p = 0,003) et la présence d’un thrombus visible sur
l’angiographie (4,54; 1,54 à 13,45, p = 0,006) sont des facteurs prédictifs indépendants de succès
de la thrombectomie.
Conclusion.— Ce travail met en évidence que la thrombectomie est efﬁcace dans la plupart
des cas, mais pas chez tous les patients. D’autres études sont maintenant nécessaires pour
développer des techniques d’aspiration plus efﬁcace et d’autres dispositifs d’aspiration pour
es procédures.
Tous droits réservés.
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Background
Primary angioplasty is the established treatment for recanal-
ization of coronary arteries during AMI. Rapid restoration of
TIMI grade 3 ﬂow is closely associated with improved survival
[1,2]. Distal embolization in patients treated with primary
PCI occurs in about 10% of patients and remains a serious
problem [3,4]. Dislodgement of the thrombus leads to distal
thromboembolization, which frequently results in dimin-
ished microcirculatory perfusion or microvascular obstruc-
[
o
s
t
tion, increased infarct size and reduced survival [1—10].
n addition to the pharmacological approaches, several
hrombectomy devices have been investigated to reduce the
isk of embolization. In 2008, Vlaar et al. randomly assigned
071 patients to initial thromboaspiration (Export Medtronic
EM], Medtronic Inc., Minneapolis, Minnesota) with stenting
r conventional primary PCI with the use of a balloon and
tent. Cardiac death at 1 year was signiﬁcantly lower in the
hrombus aspiration group when compared with the conven-
ional PCI group (respectively, 3.6% vs 6.7%; P = 0.020) [11].
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hese data were further conﬁrmed by three meta-analyses
12—14], before publication of the article by Mongeon et al.,
hich concluded that adjunctive thrombectomy had no clin-
cal beneﬁt [15]. Nevertheless, there are many thromboaspi-
ation devices, with very different technical characteristics,
nd the interventional cardiologist has to make choices.
he decision to attempt a coronary thrombectomy and
he choice of catheter could be targeted according to the
linical characteristics of the patient, the anatomical char-
cteristics of the coronary bed and the angiographic char-
cteristics of the culprit lesion. Furthermore, around 30%
f thrombectomy attempts are unsuccessful (where success
s deﬁned as recovery of atherothrombotic material either
acroscopically or after histopathological analysis). Based
n this clinical observation, we designed this study to assess
he role of clinical and angiographic ﬁndings on admission in
redicting successful thrombectomy in patients with AMI.
ethods
atient population
he participants in this study were recruited from the RICO
urvey, a French regional survey of AMI. Details on the sur-
ey have been published previously [16]. Our study cohort
onsisted of all primary and rescue PCI procedures, in the
2 hours after symptom onset, using the Export® catheter
etween the 1 January 2009 and 31December 2009. We
hen performed a retrospective analysis for patients who
et the criteria to select the study population, mean-
ng that all patients with a baseline TIMI ﬂow greater
han 1 or those who underwent a PCI procedure without
he Export® catheter were excluded. Three-hundred and
ighty eligible patients admitted for ST-segment elevation
yocardial infarction were excluded from the analysis. The
ain criterion for evaluation was successful thrombectomy,
eﬁned as a visible atherothrombotic clot in the ﬁltered,
spirated material (group T+). Otherwise, thrombectomy
as deemed to have failed (group T−). Myocardial infarc-
ion was diagnosed according to European Society of
ardiology and American College of Cardiology criteria
17].
ata collection
he following patient characteristics were collected
rospectively: age, sex and cardiovascular risk factors (his-
ory of or treated hypertension, known history of diabetes,
reated hypercholesterolaemia, current smoker [deﬁned as
ctive cigarette smoking within the 3months prior to this
dmission]). Anthropometric parameters (i.e., body mass
ndex in kg/m2) were measured within 48 hours of admis-
ion. Haemodynamic parameters on admission (heart rate,
ystolic and diastolic blood pressures) and Killip class were
lso gathered. Ischaemic time was determined by the delay
etween symptom onset and crossing the lesion with the
oppy guide wire. Patients were diagnosed with ST-segment
levation myocardial infarction when they had new or pre-
umed new ST-segment elevation greater than 1mm seen
n any location or new left bundle branch block on the
ndex or subsequent electrocardiogram. Left ventricular
a
(
a
o
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jection fraction was measured by echocardiography at
± 1 days after admission using the Simpson method. The
lobal Registry of Acute Coronary Events [18] in-hospital to
-month risk score was calculated with the published vari-
bles. Data on chronic and acute treatments administered
ithin 48 hours of admission to hospital were also collected.
oronary angiograms were reviewed by two experienced
nterventionists not involved with the procedure. Data on
he following items were collected: infarct wall location;
nal TIMI 3 ﬂow; number of diseased vessels; characteris-
ics of the culprit artery and multivessel disease; presence
f thrombus or calciﬁcations; eccentric nature of the lesion;
resence of 0, 1, ≥ 2 angles of 70◦ before the lesion; lesion
evel (ostial, proximal, middle, distal, bifurcation); diame-
er of the artery at the level of the culprit lesion; lesion
ype according the American Heart Association classiﬁca-
ion (A, B1, B2 or C); and distal embolization or no-reﬂow.
tent thrombosis was deﬁned as follows: evidence of any
yocardial infarction, with angiographic conﬁrmation of in-
tent thrombus or unexplained death within 30 days after
he procedure. Interobserver and intraobserver coefﬁcients
f variation assessed in 15 non-selected patients were 5%
nd 4%, respectively.
This study complied with the Declaration of Helsinki, was
pproved by the ethics committee of University Hospital of
ijon, and each patient gave written consent before partic-
pation.
aboratory analysis
lood samples to assess NT-pro-BNP, C-reactive protein,
lucose and creatinine concentrations were taken on admis-
ion. Median time from symptom onset to blood sampling
as 190min (85—498). Blood samples to assess NT-pro-
NP concentrations were collected in EDTA-containing tubes
nd stored at —20 ◦C before analysis (< 3 days). Plasma NT-
ro-BNP was determined by enzyme-linked immunosorbent
ssay using Elecsys NT-pro-BNP sandwich immunoassay on
lecsys 2010 (Roche Diagnostics). The inter- and intra-
ssay coefﬁcients of variation were both less than 3.1%.
he sensitivity of the assay was found to be 0.6 pg/L.
ross-reactivity with other natriuretic peptides, atrial natri-
retic peptide and C-type natriuretic peptide was less
han 0.01%. C-reactive protein was measured on Dimen-
ion Xpand (Dade Behring, Newark, NE) and creatinine on
Vittos 950 analyzer (Ortho Clinical Diagnostics Rochester,
Y). Serum creatinine clearance was estimated using the
ockcroft—Gault formula [19]. Peak plasma creatine kinase
as assessed by sampling every 8 hours during the ﬁrst 2 days
fter admission (Dimension Vista Intelligent Lab System,
iemens).
rocedural treatment
or all patients, the ﬁrst procedural step was the passing
f a ﬂoppy, steerable guide wire through the target lesion.
he usual pharmacological treatments were used before
nd during PCI, including intracoronary nitrates, aspirin
500-mg loading dose), either weight-adjusted unfraction-
ted heparin or heparin (5000 IU), and clopidogrel (300-
r 600-mg loading dose). The glycoprotein IIb/IIIa inhibitor
bciximab was used at the interventionist’s discretion.
in A
SClinical predictors of successful thrombectomy with Export®
Administration of a high-dose (50g) intracoronary bolus of
adenosine was used in most patients with AMI in whom a
primary PCI was performed. Stents implanted were either
bare metal or drug eluting. Standard therapies after PCI
according to current guidelines were continued at hospi-
tal discharge, including aspirin (> 81mg) and clopidogrel
(75mg).
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Table 1 Clinical data, medical history and treatments on adm
Group T−
(n = 25)
Men 20 (80)
Age (years) 74 (57—
BMI (kg/m2) 27 (24—
Hypertension 17 (68)
Hypercholesterolaemia 11 (44)
Diabetes mellitus 3 (12)
Family history of coronary artery disease 7 (28)
Smoker 7 (28)
History of TIA or stroke 2 (8)
Heart rate (beats/min) 78 (65—
Systolic blood pressure (mmHg) 148 (130
Diastolic blood pressure (mmHg) 85 (70—
ST-elevation myocardial infarction 19 (76)
Anterior location 12 (48)
Left ventricular ejection fraction (%) 45 (32—
Lysis 2 (8)
Ischaemic time (min) 226 (136
Cardiogenic shock 1 (4)
GRACE risk score 156 (130
Cardiovascular death at 30 days 4 (16)
Biological data
Peak creatine kinase (UI/l) 1301 (948
Creatinine clearance (mL/min) 66.10 (43.
Total cholesterol (g/l) 2.01 (1.6
Low-density lipoprotein cholesterol (g/L) 1.37 (1.0
High-density lipoprotein cholesterol (g/L) 0.45 (0.3
Triglycerides (g/L) 0.91 (0.7
C-reactive protein (mg/L) 2.99 (2.9
Glycaemia on admission (mmol/L) 7.04 (5.9
NT-pro-BNP (pg/mL) 638 (138
Chronic treatment
Aspirin 2 (8)
Clopidogrel 2 (8)
Statin 8 (32)
Vitamin K antagonist 4 (16)
Acute phase
Angiotensin-converting enzyme inhibitor 18 (72)
Aspirin 24 (96)
Beta-blocker 22 (88)
Clopidogrel 25 (100
Glycoprotein IIb/IIIa inhibitor 20 (80)
Insulin 8 (32)
Low-molecular-weight heparin 13 (52)
Statin 21 (84)
Unfractionated heparin 11 (44)
Data given as number (%) or indicated medians (25th to 75th percentile
n-terminal pro-b-type natriuretic peptide; TIA: transient ischemic attaMI 525
tatistical analysishe dichotomous data are expressed as numbers (%) and
he continuous data are expressed as medians (25th to
5th percentiles). Comparisons between the groups were
erformed either with the unpaired Student’s t test, or
ith the non-parametric Mann—Whitney U-test as appro-
ission (n = 180).
Group T+ P
(n = 155)
125 (69) 0.84
83) 61 (53—74) 0.015
29) 27 (25—30) 0.81
64 (41) 0.023
59 (38) 0.73
13 (8) 0.83
39 (25) 0.96
63 (41) 0.33
4 (3) 0.42
91) 74 (61—85) 0.18
—160) 135 (120—149) 0.031
100) 80 (70—92) 0.39
122 (79) 0.97
56 (36) 0.36
55) 50 (40—60) 0.039
25 (16) 0.45
—570) 210 (137—596) 0.996
6 (4) 0.60
—172) 139 (118—159) 0.094
8 (5) 0.11
—2535) 1511 (463—2963) 0.99
80—87.40) 81.00 (60.25—104.80) 0.019
1—2.44) 2.03 (1.75—2.25) 0.95
8—1.61) 1.31 (1.08—1.53) 0.87
8—0.56) 0.45 (0.38—0.53) 0.62
2—1.53) 1.28 (0.90—1.82) 0.13
0—7.25) 4.56 (2.90—10.60) 0.15
8—9.00) 7.07 (5.90—9.09) 0.92
—2864) 606 (96—1394) 0.39
11 (7) 0.80
7 (5) 0.81
25 (16) 0.10
5 (3) 0.026
112 (72) 0.83
150 (97) 0.69
129 (83) 0.76
) 150 (97) 0.80
108 (70) 0.41
29 (19) 0.21
99 (64) 0.36
139 (90) 0.62
52 (34) 0.43
s). GRACE: global registry of acute coronary events; NT-pro-BNP:
ck.
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riate. The Chi2 test was used for qualitative variables
nd Fisher’s exact test for small numbers of patients.
ogistic regression was performed using the backward
tepwise technique to determine the independent predic-
ors of successful thrombectomy. Results are expressed as
dds ratios (ORs) with 95% conﬁdence intervals (CIs). All
ariables listed in Tables 1 and 2 were tested by uni-
ariate analysis and only the variables with a P < 0.10
ere examined in the multivariable models. The crite-
ia used for the backward logistic regression were the
ollowing: entry in the model with a threshold at 0.05
nd exit of the model with a threshold at 0.10. A P-
alue < 0.05 was considered statistically signiﬁcant and
wo-sided tests were used. All the analyses were performed
sing the SPSS 13.0 software package (SPSS Inc, Illinois,
SA).
n
i
a
Table 2 Angiographic data (n = 180).
Stent thrombosis by 30 days
No-reﬂow (ﬁnal TIMI ﬂow 0—2)
Final TIMI 3 ﬂow
Failure of angioplasty
Administration of adenosine
Distal embolization
Culprit artery
Left anterior descending
Right coronary
Circumﬂex
Marginal
Intermediate
Left main coronary
Multivessel disease
Level of the lesion
Ostial
Proximal
Middle
Distal
Bifurcation lesion
Angulation > 70◦ before the lesion
0
1
≥ 2
Diameter of artery at the level of the lesion (mm)
Eccentric lesion
Visible thrombus
Calciﬁcations
AHA classiﬁcation
A
B1
B2
C
Data given as number (%) or indicated medians (25th to 75th percentilL. Lorgis et al.
esults
hromboaspiration was effective (Group T+) in 155 of the
80 patients (86.1%). Table 1 shows the clinical character-
stics, admission data and treatments for the two groups.
roup T+ patients were signiﬁcantly younger (61 vs 74 years,
= 0.015) and less likely to have known hypertension (41% vs
8%, P = 0.023). Among the admission parameters, the mean
ystolic arterial blood pressure was signiﬁcantly lower in
roup T+ (135 vs 148mmHg, P = 0.031). In contrast, there
as no difference between the two groups with regard to
eart rate. The mean ejection fraction was signiﬁcantly
igher in Group T+ (50% vs 45%, P = 0.039). Finally, there was
o signiﬁcant difference between the two groups concern-
ng the proportion of patients who underwent thrombolysis
nd the mean time to reperfusion.
Group T− Group T+ P
(n = 25) (n = 155)
1 (4) 2 (1) 0.89
3 (12) 25 (16) 0.85
22 (88) 130 (84) 0.69
0 (0) 3 (2) 0.89
22 (88) 120 (77) 0.35
2 (8) 7 (4.5) 0.81
12 (48) 54 (35) 0.30
9 (36) 81 (52) 0.20
2 (8) 14 (9) 0.83
1 (4) 4 (3) 0.80
0 (0) 1 (1) 0.30
1 (4) 0 (0) 0.30
16 (64) 102 (66) 0.96
2 (8) 18 (12) 0.85
7 (28) 40 (26) 0.99
15 (60) 93 (60) 0.83
3 (12) 23 (15) 0.95
6 (24) 14 (9) 0.062
8 (32) 66 (43) 0.44
15 (60) 71 (46) 0.27
2 (8) 17 (11) 0.92
3.5 (3—3.5) 3.5 (3—3.5) 0.74
16 (64) 92 (59) 0.83
7 (28) 94 (61) 0.005
15 (60) 57 (37) 0.048
0 (0) 4 (3) 0.94
6 (24) 42 (27) 0.94
19 (76) 108 (70) 0.68
0 (0) 1 (1) 0.30
es).
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Table 3 Multivariable analysis of successful thrombectomy (n = 180).
Odds ratio [95% conﬁdence interval] P
Age > 70 years 0.18 [0.06—0.51] 0.001
Systolic blood pressure (mmHg) 0.97 [0.95—0.99] 0.003
Bifurcations 0.30 [0.09—1.02] 0.054
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Table 2 summarizes the angiographic ﬁndings. In Group
T− 94% of the study population had TIMI ﬂow 0 versus 96%
in Group T+ at the time of the diagnosis angiography. The
culprit artery was most often the right coronary in Group T+,
whereas the LAD was more frequently affected in Group T−,
but the difference was not statistically signiﬁcant. There
was no difference between the two groups for the existence
of an eccentric lesion, the angulations of the artery and the
diameter of the artery. In contrast, the presence of a visible
thrombus on angiography was signiﬁcantly more frequent
in Group T+ (61% vs 28%, p = 0.005). However, calciﬁcations
were signiﬁcantly less frequent in Group T+ (37% vs 60%,
P = 0.048). The morphologic criteria of the lesions in the two
groups were similar. Finally, the proportions of ﬁnal TIMI 3
ﬂow in the culprit artery after the PCI procedure and 30-day
stent thrombosis were similar in the two groups.
In multivariable analysis, the ability to remove the clot
was affected by age greater than 70 years (OR 0.18, 95%
CI 0.06—0.51; P = 0.001), admission systolic blood pressure
(0.97, 0.95—0.99; P = 0.003) and thrombus seen on the
angiography (4.54, 1.54—13.45, P = 0.006) (Table 3).
Discussion
Manual thrombectomy is part of the therapeutic arsenal
in the acute phase of myocardial infarction, but such a
procedure is not always effective, whatever the judgment
criteria used (improvement in TIMI ﬂow, resolution of the
ST segment, macroscopic or histopathological evidence of
recovered material, for example). The criteria that deter-
mine success or failure of thromboaspiration are unknown.
Furthermore, clinicians need basic indicators to tailor revas-
cularization procedures, and additive devices are needed to
achieve the best result. There is a lack of data in the ﬁeld
of manual thrombectomy devices. Our study has identiﬁed
three independent factors associated with the success of
thrombectomy using an Export® catheter.
In the literature, we found no reports of any study
that explored the factors that predict success or failure of
thromboaspiration using the Export® catheter. Nevertheless,
Suzuki et al. [20] conducted a study on thromboaspiration
using the TVAC® system (TVAC system, Nipro, Osaka, Japan)
in a series of 80 patients. The authors reported that eccen-
tric lesions and lesions of less than 10mm in length were
associated with higher rates of success. The second study, by
Jo et al. [21] and involving 88 patients, showed that throm-
boaspiration wasmore effective on ST resolution when it was
performed on the proximal left anterior descending artery or
the right coronary artery. The study by Lee et al. [22], con-
ducted in an unselected population of 200 patients with AMI,
i
a
t
t54—13.45] 0.006
howed that ostial lesions were independently associated
ith unsuccessful thrombectomy using X-Sizer®.
In our study, the presence of a visible thrombus on angiog-
aphy seemed to be by far the strongest angiographic predic-
or of success. However, the proportion of our patients with
nal TIMI 3 ﬂow was 88% in the group with failed thrombec-
omy and 84% in the group with successful thrombectomy.
hese results are in accordance with those previously
ublished, such as in the Thrombus Aspiration during
ercutaneous coronary intervention in Acute myocardial
nfarction Study (TAPAS) [11]. Intuitively, the presence of a
isible thrombus or a large quantity of thrombotic material
fter insertion of the guide will often encourage operators
o favour this complementary technique; indeed, in many
f the published studies on thrombectomy, the population
as selected according to angiographic criteria including
he presence of a thrombus. However, it is interesting to
bserve that our results contradict those of the TAPAS trial
11], which showed that aspiration was effective whether
he thrombus was visible or not. It must be pointed out,
owever, that there were major differences between these
tudies and ours: (1) the proportion of visible thrombi was
igher in our study than in the two cited above (61% vs 49%
nd 53%, respectively); (2) our work included only patients
ith TIMI 0 or 1 ﬂow (patients in whom the thrombotic
ascade had led to the occlusion of vessels, and thus theoret-
cally a larger amount of clotting) whereas the TAPAS study
ncluded patients whatever the TIMI ﬂow; and (3) ﬁnally,
t must be noted that a visible thrombus is an operator-
ependent factor, and that it is not unusual to underestimate
he thrombotic component of the culprit lesion.
Interestingly, the ability to remove the clot was inﬂu-
nced negatively by systolic blood pressure on presentation,
erhaps because of the hydraulic forces imposed by higher
lood pressures. In addition, age greater than 70 years
as independently associated with the ability to remove
he clot; this could be explained by the existence in such
atients of lesions with a greater degree of calciﬁcation,
aking it more difﬁcult to pass the catheter through.
owever, the extent of calciﬁcation did not appear to be
n independent factor of thrombectomy failure. These
esults are similar to those reported by Flint et al. [23],
ho studied thrombectomy of the internal carotid artery in
troke. The authors reported two independent factors for
mproved prognosis: the success of the thrombectomy and
he absence of a history of hypertension; and two factors
ndependently linked to mortality: failure of thrombectomy
nd advanced age.
Finally, in our study, none of the angiographic charac-
eristics, apart from the presence of a thrombus, suggested
hat speciﬁc types of lesions were more likely to beneﬁt from
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sing the Export® catheter. However, it appeared that com-
lex lesions (calciﬁed, bifurcation, ostial and with thrombi)
educed the likelihood of success, although this was not
onﬁrmed by the American Heart Association classiﬁcation,
hich was the same in the two groups of patients.
tudy limitations
ven if our work is underpowered to establish a strong cor-
elation between thrombectomy and surrogate markers of
yocardial reperfusion, it is the ﬁrst to raise this problem,
nd a larger scale study now seems necessary to conﬁrm
hese results. The results of our study cannot be extrapo-
ated to other types of catheter.
onclusion
hrombectomy performed in routine practice during the
cute phase of myocardial infarction can be efﬁcacious.
owever, the results of the present study suggest that there
re reliable clinical factors on admission that can predict the
uccessful rate of the procedure. The possibility of recom-
ending the use of manual thrombectomy devices in future
uidelines for the management of AMI implies that studies
re now needed to clearly identify clinical and angiographic
haracteristics that predict a greater likelihood of success,
nd to explore other aspiration techniques and the impact
f different catheters.
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